bimagrumab tirzepatide

bimagrumab tirzepatide A Study to Investigate Weight Management With (LY3985863) and (LY3298176), Alone or in Combination, in Adults With Obesity or Overweight Eli Lilly halts trial testing

Name: bimagrumab tirzepatide A Study to Investigate Weight Management With (LY3985863) and (LY3298176), Alone or in Combination, in Adults With Obesity or Overweight Eli Lilly halts trial testing
Brand: pharmaregulatorysummit.com
SKU: 93058686415
Price: 27.05 USD
Availability: InStock
Rating: 4.5535000000000005 (26 reviews)

SKU: 93058686415

4.6

USD27.05 USD71.05

Pay in 4 interest-free payments of $6.76 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Description

The FDA labeling explicitly states that semaglutide should not be administered intramuscularly or intravenously

With 500+ faculty and hundreds of abstracts, experts in the field work together to share the latest clinical data, procedural guidance, and advanced expertise